Modifiers of Disease Severity in Cerebral Cavernous Malformations

Deep Phenotyping in Patients With ALS

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Riluzole in Spinal Cord Injury Study

Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol

Long-Term Evaluation of BIIB067

A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington's Disease

Genetics of Arteriovenous Malformations

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

Speech Analysis in ALS Patients

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Study of BHV-4157 in Alzheimer's Disease

To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine

Troriluzole in Adult Subjects With Spinocerebellar Ataxia

Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers

An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)

A Study of LY3154207 in Participants With Parkinson's Disease Dementia

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks